Skip to content

GENEREX BIOTECHNOLOGY CORP: 10-K filed 2012-10-15

What GENEREX BIOTECHNOLOGY CORP reported in its annual report filed 2012-10-15 (fiscal FY 2012): 38 published measures, 193 facts as tagged in accession 0001144204-12-056138.

This filing

Form
10-K (annual report)
Filed
2012-10-15
Fiscal period
fiscal FY 2012
Accession
0001144204-12-056138 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENEREX BIOTECHNOLOGY CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-07-314,644,374USD
At 2011-07-3112,006,365USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-07-3113,024,565USD
At 2011-07-3120,448,501USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-07-31-8,380,191USD
At 2012-04-30-7,651,468USD
At 2011-07-31-8,442,136USD
At 2010-07-318,970,620USD
At 2009-07-3114,223,742USD
At 2008-07-3122,646,807USD
At 2007-07-3136,070,592USD
At 2006-07-3155,463,794USD
At 2005-07-316,127,003USD
At 2004-07-31529,751USD
At 2003-07-315,856,965USD
At 2002-07-3112,862,592USD
At 2001-07-3127,307,440USD
At 2000-07-318,415,025USD
At 1999-07-317,309,849USD
At 1998-07-312,642,299USD
At 1997-07-313,448,836USD
At 1996-07-312,015,624USD
At 1995-10-310USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-07-31246,309USD
At 2011-07-312,798,797USD
At 2011-04-303,565,484USD
At 2010-07-3113,880,870USD
At 2009-07-3114,197,048USD
At 2008-07-3117,237,510USD
At 1995-10-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-1,575,838USD92
2011-08-01 to 2012-07-31-9,490,278USD366
1995-11-04 to 2012-07-31-354,173,560USD6115
2012-01-30 to 2012-04-30867,857USD92
2011-11-01 to 2012-01-31-9,118,651USD92
2011-08-01 to 2011-10-31336,354USD92
2011-05-01 to 2011-07-31-5,444,741USD92
2010-07-31 to 2011-07-31-21,675,867USD366
2011-01-29 to 2011-04-30-4,116,953USD92
2010-11-01 to 2011-01-31-5,236,906USD92
2010-08-01 to 2010-10-31-6,877,267USD92
2009-07-31 to 2010-07-31-25,279,940USD366
2008-07-31 to 2009-07-31-45,812,228USD366
2007-08-01 to 2008-07-31-36,228,991USD366
2006-07-31 to 2007-07-31-23,504,958USD366
2005-07-31 to 2006-07-31-67,967,204USD366
2004-07-31 to 2005-07-31-24,001,735USD366
2003-08-01 to 2004-07-31-18,362,583USD366
2002-07-31 to 2003-07-31-13,261,764USD366
2001-07-31 to 2002-07-31-13,693,034USD366
2000-07-31 to 2001-07-31-27,097,210USD366
1999-08-01 to 2000-07-31-8,841,047USD366
1998-07-31 to 1999-07-31-6,239,602USD366
1997-07-31 to 1998-07-31-4,663,604USD366
1996-07-31 to 1997-07-31-1,379,024USD366
1995-10-31 to 1996-07-31-693,448USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-08-01 to 2012-07-31-8,043,979USD366
1995-11-04 to 2012-07-31-216,599,398USD6115
2010-07-31 to 2011-07-31-16,931,368USD366
2009-07-31 to 2010-07-31-22,312,127USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-08-01 to 2012-07-312,416USD366
1995-11-04 to 2012-07-314,809,439USD6115
2010-07-31 to 2011-07-3152,383USD366
2009-07-31 to 2010-07-31159,708USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-08-01 to 2012-07-31746,477USD366
1995-11-04 to 2012-07-31223,063,713USD6115
2010-07-31 to 2011-07-316,130,127USD366
2009-07-31 to 2010-07-3122,334,371USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-08-01 to 2012-07-314,777,134USD366
1995-11-04 to 2012-07-31-6,135,427USD6115
2010-07-31 to 2011-07-31-287,367USD366
2009-07-31 to 2010-07-31-388,485USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-07-31704,678USD
At 2011-07-311,271,867USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-2,301,769USD92
2011-08-01 to 2012-07-31-10,024,048USD366
1995-11-04 to 2012-07-31-286,155,471USD6115
2012-01-30 to 2012-04-30-2,466,270USD92
2011-11-01 to 2012-01-31-1,786,231USD92
2011-08-01 to 2011-10-31-3,469,778USD92
2011-05-01 to 2011-07-31-5,729,745USD92
2010-07-31 to 2011-07-31-24,533,082USD366
2011-01-29 to 2011-04-30-5,061,959USD92
2010-11-01 to 2011-01-31-5,967,558USD92
2010-08-01 to 2010-10-31-7,773,820USD92
2009-07-31 to 2010-07-31-29,429,817USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-07-31446,861USD
At 2011-07-313,749,981USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-08-01 to 2012-07-31592,525USD366
1995-11-04 to 2012-07-3169,008,682USD6115
2010-07-31 to 2011-07-31208,906USD366
2009-07-31 to 2010-07-31210,083USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-07-318,501,523USD
At 2011-07-319,318,198USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-07-312,634,458USD
At 2011-07-313,349,588USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-07-310USD
At 2011-07-318,690USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2011-08-01 to 2012-07-310USD366
1995-11-04 to 2012-07-31497,522USD6115
2010-07-31 to 2011-07-310USD366
2009-07-31 to 2010-07-310USD366

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-08-01 to 2012-07-3110,041,590USD366
1995-11-04 to 2012-07-31289,645,880USD6115
2010-07-31 to 2011-07-3124,669,091USD366
2009-07-31 to 2010-07-3129,790,162USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-07-310USD
At 2011-07-31717,442USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-08-01 to 2012-07-3117,542USD366
1995-11-04 to 2012-07-313,490,409USD6115
2010-07-31 to 2011-07-31136,009USD366
2009-07-31 to 2010-07-31360,345USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-08-01 to 2012-07-314,987,236USD366
1995-11-04 to 2012-07-31131,975,964USD6115
2010-07-31 to 2011-07-3110,250,397USD366
2009-07-31 to 2010-07-3113,361,156USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-07-31354,161,297shares
At 2011-07-31308,519,768shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-07-31777,615USD
At 2011-07-31869,575USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-07-311,664,161USD
At 2011-07-313,080,066USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-07-311,569,088USD
At 2011-07-316,711,767USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-07-31864,410USD
At 2011-07-315,439,900USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-08-01 to 2012-07-31-9,490,278USD366
1995-11-04 to 2012-07-31-357,211,745USD6115
2010-07-31 to 2011-07-31-21,675,867USD366
2009-07-31 to 2010-07-31-25,279,940USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2011-08-01 to 2012-07-31-8,902,540USD366
2010-07-31 to 2011-07-31-21,590,475USD366
2009-07-31 to 2010-07-31-25,147,344USD366
2008-07-31 to 2009-07-31-46,075,136USD366
2007-08-01 to 2008-07-31-36,196,303USD366
2006-07-31 to 2007-07-31-23,377,232USD366
2005-07-31 to 2006-07-31-67,781,972USD366
2004-07-31 to 2005-07-31-23,729,257USD366
2003-08-01 to 2004-07-31-18,154,990USD366
2002-07-31 to 2003-07-31-12,854,934USD366
2001-07-31 to 2002-07-31-13,764,219USD366
2000-07-31 to 2001-07-31-27,178,551USD366
1999-08-01 to 2000-07-31-8,808,533USD366
1998-07-31 to 1999-07-31-6,238,209USD366
1997-07-31 to 1998-07-31-4,862,563USD366
1996-07-31 to 1997-07-31-1,375,481USD366
1995-10-31 to 1996-07-31-697,465USD275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-1,575,838USD92
2011-08-01 to 2012-07-31-9,867,024USD366
1995-11-04 to 2012-07-31-357,611,780USD6115
2012-01-30 to 2012-04-30491,111USD92
2011-11-01 to 2012-01-31-9,118,651USD92
2011-08-01 to 2011-10-31336,354USD92
2011-05-01 to 2011-07-31-6,211,158USD92
2010-07-31 to 2011-07-31-22,442,284USD366
2011-01-29 to 2011-04-30-4,116,953USD92
2010-11-01 to 2011-01-31-5,236,906USD92
2010-08-01 to 2010-10-31-6,877,267USD92
2009-07-31 to 2010-07-31-25,279,940USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-08-01 to 2012-07-314,889,179USD366
1995-11-04 to 2012-07-31147,802,156USD6115
2010-07-31 to 2011-07-3113,392,920USD366
2009-07-31 to 2010-07-3112,719,239USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-08-01 to 2012-07-3197,967USD366
2010-07-31 to 2011-07-31172,250USD366
2009-07-31 to 2010-07-31238,253USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-08-01 to 2012-07-31612,658USD366
1995-11-04 to 2012-07-319,908,540USD6115
2010-07-31 to 2011-07-31742,961USD366
2009-07-31 to 2010-07-31780,250USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-08-01 to 2012-07-31440,780USD366
1995-11-04 to 2012-07-311,353,976USD6115
2010-07-31 to 2011-07-310USD366
2009-07-31 to 2010-07-310USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-08-01 to 2012-07-310USD366
1995-11-04 to 2012-07-31686,303USD6115
2010-07-31 to 2011-07-31489,292USD366
2009-07-31 to 2010-07-31750USD366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2011-08-01 to 2012-07-310USD366
2010-07-31 to 2011-07-310USD366
2009-07-31 to 2010-07-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-08-01 to 2012-07-310USD366
1995-11-04 to 2012-07-31120,576,242USD6115
2010-07-31 to 2011-07-313,939,000USD366
2009-07-31 to 2010-07-3120,900,289USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-08-01 to 2012-07-31-8,470USD366
1995-11-04 to 2012-07-3115,047USD6115
2010-07-31 to 2011-07-31-62,200USD366
2009-07-31 to 2010-07-3112,482USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-08-01 to 2012-07-31-716,392USD366
1995-11-04 to 2012-07-3120,091USD6115
2010-07-31 to 2011-07-31-1,197,768USD366
2009-07-31 to 2010-07-31618,401USD366

Inspect the source

Entity
GENEREX BIOTECHNOLOGY CORP / CIK 0001059784
Captured
SEC response SHA-256
a8779b8c3aa8286320834b30d50af09999238cecacb9e7883d21e11477763a4d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001059784.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))